FindTrial
Sign In

EFFICACY OF ZINC AND PROBITOTICS TO PREVENT JAUNDICE

A Randomized Controlled Trial to Assess Preventive Efficacy of Zinc and Probiotics on Neonatal Jaundice in Term Newborns - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/114025
Enrollment
304
Registered
2026-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Lakshmi Priya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: TERM BABIES OF BIRTH WEIGHT MORE THAN 2500GRAM WITH APGAR MORE THAN 7 AND EXCLUSIVELY BREAST FED BABIES WITH NO RISK FACTOR FOR JAUNDICE

Exclusion criteria

Exclusion criteria: BABIES WITH RISK FACTOR FOR HEMOLYTIC JAUNDICE OR SEPSIS OR HYPOTHYROIDISM OR UMBILICAL HERNIA OR CONGENTIAL ANOMALIES OR REQUIRING NICU ADMISSION

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of zinc and probiotics on the incidence of neonatal jaundice requiring interventionTimepoint: serum bilirubin levels measured at 48 hours and 72 hours of life—

Secondary

MeasureTime frame
NILTimepoint: nil—

Countries

India

Contacts

Public ContactLAKSHMI PRIYA

PANIMALAR MEDICAL COLLEGE HOSPITAL AND RESEARCH INSTITUTE

lapriya90@gmail.com9092291000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026